BRAF and radiodermatitis: In patients receiving concurrent BRAF inhibitor with whole brain radiotherapy, the incidence of radiodermatitis was significantly greater in patients receiving combined therapy: reported as 44% for combination compared to 8% receiving radiation alone (82).